Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted

December 20, 2023 Please see attachment. Contact informationInvestor RelationsDisa Tuominen +45 6038 5826dkditu@chr-hansen.comPress RelationsSanne Seyer-Hansen +45 6038 6207dksash@chr-hansen.comAttachment 2023_South Korean merger approval granted

December 20, 2023

Please see attachment.

Contact information

Investor Relations
Disa Tuominen
+45 6038 5826
dkditu@chr-hansen.com

Press Relations
Sanne Seyer-Hansen
+45 6038 6207
dksash@chr-hansen.com

Attachment

• 2023_South Korean merger approval granted